- 专利标题: Methods for manufacturing T cells by direct sorting and compositions thereof
-
申请号: US16893246申请日: 2020-06-04
-
公开(公告)号: US12011459B2公开(公告)日: 2024-06-18
- 发明人: Amir Alpert , Dominik Maurer , Anastasiya Smith , Claudia Wagner , Ali Mohamed
- 申请人: Immatics US, Inc. , Immatics Biotechnologies GmbH
- 申请人地址: US TX Houston
- 专利权人: IMMATICS US, INC.,IMMATICS BIOTECHNOLOGIES GMBH
- 当前专利权人: IMMATICS US, INC.,IMMATICS BIOTECHNOLOGIES GMBH
- 当前专利权人地址: US TX Houston; DE Tübingen
- 代理机构: MeBee, Moore & Vanik IP, LLC
- 优先权: DE 2019129341.3 2019.10.30
- 主分类号: A61K35/17
- IPC分类号: A61K35/17 ; A61K31/437 ; A61K31/5383 ; A61K35/76 ; C07K14/47 ; C07K14/725 ; C12N5/0783 ; G01N15/14 ; G01N33/554 ; G01N15/10 ; G01N15/149
摘要:
Described herein are methods for preparing T cells, including isolating CD8+ T cells from a blood sample obtained from a patient or a donor, culturing the isolated CD8+ T cells in the presence of at least one cytokine, contacting the cultured CD8+ T cells with a multimer containing a target peptide in a complex with an MHC molecule and with at least one binding agent that binds to a T cell surface molecule, in which the multimer is labelled with a first detectable agent and the binding agent is labelled with a second detectable agent, sorting the contacted CD8+ T cells to collect the sorted CD8+ T cells that are detected positive for the first and the second detectable agents, and expanding the collected CD8+ T cells.
公开/授权文献
信息查询
IPC分类: